# US 2024/0189602 A1 · Method and apparatus for detecting cardiac event oversensing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189602 A1
- Document ID: US20240189602A1
- Status: Published application
- Kind: A1
- Application number: 18/444,625
- Filed: 2024-02-16
- Published: 2024-06-13
- Earliest claimed: 2019-12-09
- Assignees: Medtronic, Inc.
- Applicants: Medtronic, Inc.
- Inventors: Gavin M. MISCHLER; Yuanzhen LIU; Saul E. GREENHUT; Xusheng ZHANG
- Web page: https://patentgrep.com/patent/US20240189602A1

## CPC

- A61N 1/3621: {for treating or preventing abnormally high heart rate}
- A61N 1/3925: {Monitoring; Protecting}
- A61B 5/287: Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
- A61B 5/352: Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
- A61B 5/363: Detecting tachycardia or bradycardia
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61B 5/7221: {Determining signal validity, reliability or quality (preventing, reducing or removing noise induced by motion artefacts A61B5/7207; noise originating from a therapeutic or surgical apparatus A61B5/7217)}
- A61B 5/7282: {Event detection, e.g. detecting unique waveforms indicative of a medical condition (cough events A61B5/0823; seizures A61B5/4094; sleep apnoea A61B5/4818)}
- A61N 1/365: controlled by a physiological parameter, e.g. heart potential {(evoked response A61N1/371)}
- A61N 1/3704: {Circuits specially adapted therefor, e.g. for sensitivity control}
- A61N 1/3706: {Pacemaker parameters (stimulation threshold A61N1/371)}
- A61N 1/3956: {Implantable devices for applying electric shocks to the heart, e.g. for cardioversion}
- A61N 1/3987: {characterised by the timing or triggering of the shock}
- A61B 5/35: by template matching
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A medical device is configured to detect an alternating pattern of signal features determined from consecutive segments of a cardiac electrical signal and determine a gross morphology metric from at least one segment of the cardiac electrical signal. The device is configured to detect cardiac event oversensing in response to detecting the alternating pattern and the gross morphology metric not meeting tachyarrhythmia morphology criteria. The medical device may withhold detecting an arrhythmia in response to detecting the cardiac event oversensing.

## Claims

### Claim 1

A medical device comprising:
a cardiac electrical signal sensing circuit configured to sense a plurality of cardiac electrical signals;
a control circuit configured to:
determine signal features from the plurality of cardiac electrical signals;
detect an alternating pattern of the signal features;
identify, based on the alternating pattern of the signal features, at least one segment of the plurality of cardiac electrical signals that is a suspected R-wave;
from the at least one segment identified as a suspected R-wave, determine at least one of:
a maximum signal pulse width; or
an amplitude metric;
based on at least one of the maximum signal pulse width or the amplitude metric, determine that the suspected R-wave is one of:
a tachyarrhythmia morphology; or
a true sensed R-wave;
detect a tachyarrhythmia in response to at least determining the suspected R-wave is the tachyarrhythmia morphology; and
withhold detecting the tachyarrhythmia in response to at least determining that the suspected R-wave is the true sensed R-wave; and
a therapy delivery circuit configured to deliver a tachyarrhythmia therapy in response to the control circuit detecting the tachyarrhythmia.

### Claim 2 (depends on 1)

The medical device of claim 1 wherein:
the sensing circuit is further configured to:
sense a first cardiac electrical signal of the plurality of cardiac electrical signals;
sense a second cardiac electrical signal of the plurality of cardiac electrical signals; and
sense cardiac event signals from the first cardiac electrical signal:
the control circuit is further configured to detect the alternating pattern of signal features from the second cardiac electrical signal.

### Claim 3 (depends on 2)

The medical device of claim 2 further comprising:
a memory configured to store segments of the second cardiac electrical signal, each stored segment corresponding in time to one of the sensed cardiac event signals; and
wherein the control circuit is further configured to detect the alternating pattern of signal features from the stored segments of the second cardiac electrical signal.

### Claim 4 (depends on 3)

The medical device of claim 3 wherein the control circuit is further configured to:
determine the signal features from a first group of three consecutively sensed segments of the stored segments;
detect one of a high-low-high pattern or a low-high-low pattern of the signal features of the first group of three consecutively sensed segments; and
identify the suspected R-wave based on the alternating pattern of signal features as at least one of the first group of the three consecutively sensed segments determined to be a high signal feature of the high-low-high or the low-high-low pattern.

### Claim 5 (depends on 4)

The medical device of claim 4 wherein the control circuit is further configured to:
determine the signal features from a plurality of groups of three consecutively sensed segments of the stored segments including the first group of three consecutively sensed segments;
for each of the plurality of groups of three consecutively sensed segments:
determine if the signal features are an alternating pattern; and
if the signal features are an alternating pattern, identify at least one segment of the three consecutively sensed segments that is a suspected R-wave;
determine that the suspected R-wave is one of:
a tachyarrhythmia morphology; or
a true sensed R-wave; and
increase a P-wave oversensing count when the signal features are an alternating pattern and the suspected R-wave is determined to be a true sensed R-wave and not the tachyarrhythmia morphology;
determine if the P-wave oversensing count meets a tachyarrhythmia rejection threshold; and
detect the tachyarrhythmia in response to at least determining the suspected R-wave is the tachyarrhythmia morphology by determining that the P-wave oversensing count does not meet the tachyarrhythmia rejection threshold; and
withhold detecting the tachyarrhythmia in response to at least determining that the suspected R-wave is the true sensed R-wave by determining that the P-wave oversensing count meets the tachyarrhythmia rejection threshold.

### Claim 6 (depends on 5)

The medical device of claim 5 wherein the control circuit is further configured to, for each of the plurality of groups of three consecutively sensed segments:
when the signal features are not determined to be an alternating pattern or the suspected R-wave is determined to be a tachyarrhythmia morphology, do not increase the P-wave oversensing count; and
advance to a next group of the plurality of groups of three consecutively sensed segments for determining if the signal features are an alternating pattern, wherein the groups of three consecutively sensed segments are overlapping groups of three consecutively sensed segments.

### Claim 7 (depends on 2)

The medical device of claim 2 wherein the control circuit is further configured to:
determine from the sensed cardiac event signals that a detection threshold number of tachyarrhythmia intervals is met;
detect the tachyarrhythmia in response to determining that the detection threshold number of tachyarrhythmia intervals is met and at least determining that the suspected R-wave is the tachyarrhythmia morphology; and
withhold detecting the tachyarrhythmia in response to determining that the detection threshold number of tachyarrhythmia intervals is met and at least determining that the suspected R-wave is the true sensed R-wave.

### Claim 8 (depends on 2)

The medical device of claim 2 wherein the control circuit is further configured to:
detect a first threshold number of tachyarrhythmia intervals from the sensed cardiac event signals; and
responsive to detecting the first threshold number of tachyarrhythmia intervals determine the signal features for detecting the alternating pattern of the signal features.

### Claim 9 (depends on 1)

The medical device of claim 1 wherein the control circuit is further configured to determine the signal features as peak to peak amplitudes.

### Claim 10 (depends on 1)

The medical device of claim 1 wherein the control circuit is further configured to determine the at least one of the maximum signal pulse width or the amplitude metric of the at least one segment identified as a suspected R-wave by:
determining the maximum signal pulse width by:
identifying a plurality of signal pulses of the segment;
determining a signal pulse width of each of the plurality of signal pulses; and
determining a maximum signal pulse width out of the determined signal pulse widths; or
determining the amplitude metric by:
determining a maximum amplitude of the segment;
determining a summation of a plurality of sample point amplitudes of the segment; and
dividing the summation by the maximum amplitude.

### Claim 11

A method comprising:
sensing a plurality of cardiac electrical signals;
determining signal features from the plurality of cardiac electrical signals;
detecting an alternating pattern of the signal features;
identifying, based on the alternating pattern of the signal features, at least one segment of the plurality of cardiac electrical signals that is a suspected R-wave;
from the at least one segment identified as a suspected R-wave, determining at least one of:
a maximum signal pulse width; or
an amplitude metric;
based on at least one of the maximum signal pulse width or the amplitude metric, determining that the suspected R-wave is one of:
a tachyarrhythmia morphology; or
a true sensed R-wave;
detecting a tachyarrhythmia in response to at least determining the suspected R-wave is the tachyarrhythmia morphology;
withholding detecting the tachyarrhythmia in response to at least determining that the suspected R-wave is the true sensed R-wave; and
delivering a tachyarrhythmia therapy in response to detecting the tachyarrhythmia.

### Claim 12 (depends on 11)

The method of claim 11 further comprising:
sensing a first cardiac electrical signal of the plurality of cardiac electrical signals;
sensing a second cardiac electrical signal of the plurality of cardiac electrical signals;
sensing cardiac event signals from the first cardiac electrical signal; and
detecting the alternating pattern of signal features from the second cardiac electrical signal.

### Claim 13 (depends on 12)

The method of claim 12 further comprising:
storing segments of the second cardiac electrical signal in a memory of a medical device, each stored segment corresponding in time to one of the sensed cardiac event signals; and
detecting the alternating pattern of signal features from the stored segments of the second cardiac electrical signal.

### Claim 14 (depends on 13)

The method of claim 13 further comprising:
determining the signal features from a first group of three consecutively sensed segments of the stored segments;
detecting one of a high-low-high pattern or a low-high-low pattern of the signal features of the first group of three consecutively sensed segments; and
identifying the at least on segment that is a suspected R-wave based on the alternating pattern of signal features as one of the first group of the three consecutively sensed segments that is determined to be a high signal feature of the high-low-high or the low-high-low pattern.

### Claim 15 (depends on 14)

The method of claim 14 further comprising:
determining the signal features from the plurality of groups of three consecutively sensed segments of the stored segments including the first group of three consecutively sensed segments;
for each of the plurality of groups of three consecutively sensed segments:
determining if the signal features are an alternating pattern; and
if the signal features are an alternating pattern, identifying at least one segment of the three consecutively sensed segments that is a suspected R-wave;
determining that the suspected R-wave is one of:
a tachyarrhythmia morphology; or
a true sensed R-wave; and
increasing a P-wave oversensing count when the signal features are an alternating pattern and the suspected R-wave is a true sensed R-wave and not a tachyarrhythmia morphology;
determine if the P-wave oversensing count meets a tachyarrhythmia rejection threshold; and
detect the tachyarrhythmia in response to at least determining the suspected R-wave is the tachyarrhythmia morphology by determining that the P-wave oversensing count does not meet the tachyarrhythmia rejection threshold; and
withhold detecting the tachyarrhythmia in response to at least determining that the suspected R-wave is the true sensed R-wave by determining that the P-wave oversensing count meets the tachyarrhythmia rejection threshold.

### Claim 16 (depends on 15)

The method of claim 15 further comprising, for each of the plurality of groups of three consecutively sensed segments:
when the signal features are not determined to be an alternating pattern or the suspected R-wave is determined to be a tachyarrhythmia morphology, not increasing the P-wave oversensing count; and
advancing to a next group of the plurality of groups of three consecutively sensed segments for determining if the signal features are an alternating pattern wherein the plurality of groups of three consecutively sensed segments are overlapping groups of three consecutively sensed segments.

### Claim 17 (depends on 12)

The method of claim 12 further comprising:
determining from the sensed cardiac event signals that a detection threshold number of tachyarrhythmia intervals is met;
detecting the tachyarrhythmia in response to determining that the detection threshold number of tachyarrhythmia intervals is met and at least determining that the suspected R-wave is the tachyarrhythmia morphology; and
withholding detecting the tachyarrhythmia in response to determining that the detection threshold number of tachyarrhythmia intervals is met and at least determining that the suspected R-wave is the true sensed R-wave.

### Claim 18 (depends on 12)

The method of claim 12 further comprising:
detecting a first threshold number of tachyarrhythmia intervals from the sensed cardiac event signals; and
responsive to detecting the first threshold number of tachyarrhythmia intervals determining the signal features for detecting the alternating pattern of the signal features.

### Claim 19 (depends on 11)

The method of claim 11 further comprising determining the signal features as peak to peak amplitudes.

### Claim 20 (depends on 11)

The method of claim 11 further comprising determining the at least one of the maximum signal pulse width or the amplitude metric of the at least one segment identified as a suspected R-wave by:
determining the maximum signal pulse width by:
identifying a plurality of signal pulses of the segment;
determining a signal pulse width of each of the plurality of signal pulses; and
determining a maximum signal pulse width out of the determined signal pulse widths; or
determining the amplitude metric by:
determining a maximum amplitude of the segment;
determining a summation of a plurality of sample point amplitudes of the segment; and
dividing the summation by the maximum amplitude.

### Claim 21

A non-transitory computer-readable medium storing a set of instructions which, when executed by a control circuit of a medical device, cause the medical device to:
sense a plurality of cardiac electrical signals;
determine signal features from the plurality of cardiac electrical signals;
detect an alternating pattern of the signal features;
identify, based on the alternating pattern of the signal features, at least one segment of the plurality of cardiac electrical signals that is a suspected R-wave;
from the at least one segment identified as a suspected R-wave, determine at least one of:
a maximum signal pulse width; or
an amplitude metric;
based on at least one of the maximum signal pulse width or the amplitude metric, determine that the suspected R-wave is one of:
a tachyarrhythmia morphology; or
a true sensed R-wave;
detect a tachyarrhythmia in response to at least determining the suspected R-wave is the tachyarrhythmia morphology;
withhold detecting the tachyarrhythmia in response to at least determining that the suspected R-wave is the true sense R-wave; and
deliver a tachyarrhythmia therapy in response to detecting the tachyarrhythmia.
